The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
DNLI · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
BEAM · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | DNLI | QUCY | MRNA | BEAM |
|---|---|---|---|---|
| Moat Score (0–100) | 35 (highest) | 35 (highest) | 35 (highest) | 35 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 60 (highest) | 20 | 15 | 60 (highest) |
| Pricing power | — | 94 (highest) | 70 | — |
| Returns on capital | 0 | 0 | 10 (highest) | 0 |
| Balance-sheet safety | 55 (highest) | 28 | 55 (highest) | 55 (highest) |
| Capital discipline | 24 | 33 (highest) | 24 | 24 |
| Price vs. high estimate | No price data | No price data | No price data | No price data |
| Market cap | $3.6B | $11.1M | $22.7B | $2.7B |
| Moat tier | No moat | No moat | No moat | No moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |